Novocure Newsroom

NovoCure Analyst Ratings

BenzingaNov 22 02:01

NovoCure's Buy Rating Backed by FDA Approval and Strategic Growth Plans Amidst Potential Risks

TipRanksNov 21 23:34

H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $30

Futu NewsNov 21 23:32

Analysts Conflicted on These Healthcare Names: Penumbra (PEN), Kymera Therapeutics (KYMR) and NovoCure (NVCR)

TipRanksNov 5 20:42

NovoCure Analyst Ratings

BenzingaOct 31 17:35

H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $30

Futu NewsOct 30 23:31

Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $28

Futu NewsOct 25 20:35

Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $28

Futu NewsOct 17 18:36

Leerink Partners Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $28

Futu NewsOct 17 03:31

A Quick Look at Today's Ratings for Novocure(NVCR.US), With a Forecast Between $28 to $40

Futu NewsOct 16 21:04

Piper Sandler Reaffirms Their Buy Rating on NovoCure (NVCR)

TipRanksOct 16 20:10

NovoCure Analyst Ratings

BenzingaOct 16 18:13

Buy Rating Affirmed for NovoCure as FDA Approval Expands Optune's Market Potential

TipRanksOct 16 08:00

Novocure Is Maintained at In-Line by Evercore ISI Group

Dow JonesOct 2 01:05

NovoCure Analyst Ratings

BenzingaOct 2 00:57

Evercore Maintains Novocure(NVCR.US) With Hold Rating, Cuts Target Price to $18

Futu NewsOct 1 21:31

Wells Fargo Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $40

Futu NewsSep 4 17:32

Wells Fargo Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $40

Futu NewsJul 26 19:31

Wells Fargo Remains a Buy on NovoCure (NVCR)

TipRanksJul 26 19:25

Novocure Price Target Raised to $24.00/Share From $22.00 by HC Wainwright & Co.

Dow JonesJul 26 18:04